NIH-funded research R01 grant

Targeting lineage plasticity to slow basal-like breast cancer progression

Official title: Targeting lineage plasticity to inhibit basal-like breast cancer progression

Funded at Albert Einstein College of Medicine · NIH-11428666 · Data updated 2026-11-12

A researcher team wants to find ways to stop a highly aggressive form of breast cancer by blocking how cancer cells change identity.

More Breast Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2026
Award (this year)$190,466
NIH project number3R01CA289734-02S1
Project IDNIH-11428666 on NIH RePORTER

Who could benefit from this research

Could help

People with basal-like breast cancer or BRCA1-related breast cancer who may benefit from therapies targeting cell differentiation pathways.

Less likely to help

Patients whose cancer does not involve lineage plasticity or SOX9-driven de-differentiation may see limited benefit.

What this research studies

This project looks at basal-like breast cancer, which often affects younger people and those with BRCA1 mutations, and tries to limit its spread by preventing cancer cells from changing into more dangerous forms. Using mouse models, the team will study SOX9 and the process of dedifferentiation that helps cancers become multipotent and invasive. The work aims to identify targets that could stop this change and reduce resistance to chemotherapy. If successful, the findings could lead to new strategies to treat BLBC with fewer side effects and better outcomes.

Why it matters

Potential benefit: If successful, this work could lead to new therapies that limit cancer cell plasticity and improve survival for patients with basal-like breast cancer.

How similar studies have gone: Earlier studies in mouse models suggest that blocking de-differentiation can prevent progression, indicating this approach may be promising but requires human validation.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Guo, Wenjun — Albert Einstein College of Medicine
  • Study coordinator: Guo, Wenjun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.